IN2014MU01186A - - Google Patents
Info
- Publication number
- IN2014MU01186A IN2014MU01186A IN1186MU2014A IN2014MU01186A IN 2014MU01186 A IN2014MU01186 A IN 2014MU01186A IN 1186MU2014 A IN1186MU2014 A IN 1186MU2014A IN 2014MU01186 A IN2014MU01186 A IN 2014MU01186A
- Authority
- IN
- India
- Prior art keywords
- cyclobenzaprine
- salts
- preparing
- composition
- release
- Prior art date
Links
- JURKNVYFZMSNLP-UHFFFAOYSA-N cyclobenzaprine Chemical compound C1=CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 JURKNVYFZMSNLP-UHFFFAOYSA-N 0.000 abstract 3
- 229960003572 cyclobenzaprine Drugs 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 3
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000008203 oral pharmaceutical composition Substances 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- 208000007101 Muscle Cramp Diseases 0.000 abstract 1
- 208000005392 Spasm Diseases 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000036470 plasma concentration Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 229920003176 water-insoluble polymer Polymers 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1186MU2014 IN2014MU01186A (enExample) | 2014-03-29 | 2015-03-17 | |
| PCT/IB2015/051942 WO2015150948A1 (en) | 2014-03-29 | 2015-03-17 | Modified release solid oral pharmaceutical compositions of cyclobenzaprine or a salt thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1186MU2014 IN2014MU01186A (enExample) | 2014-03-29 | 2015-03-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MU01186A true IN2014MU01186A (enExample) | 2015-10-02 |
Family
ID=54395515
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1186MU2014 IN2014MU01186A (enExample) | 2014-03-29 | 2015-03-17 |
Country Status (1)
| Country | Link |
|---|---|
| IN (1) | IN2014MU01186A (enExample) |
-
2015
- 2015-03-17 IN IN1186MU2014 patent/IN2014MU01186A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021000071A (es) | Uso de pridopidina para mejorar la funcion cognitiva y para tratamiento de enfermedad de alzheimer. | |
| PH12017500746B1 (en) | Carbidopa and l-dopa prodrugs and their use to treat parkinson's disease | |
| TN2017000119A1 (en) | Indole carboxamides compounds useful as kinase inhibitors | |
| MX382162B (es) | Combinaciones farmacéuticas de un inhibidor de enzima hdac con un inhibidor de proteasoma, y su uso en el tratamiento de cáncer. | |
| MY192055A (en) | Compounds and compositions for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation | |
| MX2017004618A (es) | Inhibidores de la biosintesis de sulfato de heparano para el tratamiento de enfermedades. | |
| PH12016502352A1 (en) | Pharmaceutical composition | |
| TW201613578A (en) | Pharmaceutical combinations | |
| MA39765A (fr) | Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation | |
| EP4324454A3 (en) | Cross-linking agents and associated methods | |
| MX381440B (es) | Composicion farmaceutica para tratar colitis ulcerativa. | |
| FI3445351T3 (fi) | Asetyylileusiini tai sen farmaseuttisesti hyväksyttävä suola liikkuvuuden parantamiseen | |
| MX376029B (es) | Compuestos de isoindol. | |
| PH12017501304A1 (en) | Levodopa and carbidopa intestinal gel and method of use | |
| MX2018003380A (es) | Formulaciones de olanzapina de liberacion sostenida. | |
| PH12012502093A1 (en) | Composition for preventing or treating osteoporosis, and manufacturing method therefor | |
| MX2020005438A (es) | Formas de dosificacion de sulfato de morfina disuasivas del abuso. | |
| IN2014MU01186A (enExample) | ||
| IN2014MU01187A (enExample) | ||
| IN2014MU01184A (enExample) | ||
| IN2014MU01185A (enExample) | ||
| EA201400960A1 (ru) | Применение модафинила для лечения кокаиновой зависимости | |
| IN2013MU01155A (enExample) | ||
| IN2013MU01154A (enExample) | ||
| IN2013MU03427A (enExample) |